Important Disclaimer: This calculator is for informational purposes only and is NOT a substitute for professional medical advice. Always verify your dose with your healthcare provider. We are not responsible or liable for any consequences of using this tool.
Dose Calculator
Semaglutide Dosage Calculator
Semaglutide Dosage Cheat Sheet
| Dosage (mg) | Units |
|---|
Tirzepatide Dosage Calculator
Tirzepatide Dosage Cheat Sheet
| Dosage (mg) | Units |
|---|
GLP-1
Exclusive Semaglutide Treatment Offer
Begin your wellness journey with our Semaglutide treatment program, starting at just $151 monthly. This program offers a flexible dosage schedule ranging from 0.25mg to 2.5mg, designed to optimize weight loss effectively over time. Payments are made monthly, with an additional shipping fee of $20 to ensure a seamless and hassle-free experience as you work towards better health.
After the initial phase, continue your Semaglutide treatment with a plan tailored to your unique health needs. Our personalized pricing adjusts based on your specific dosage and treatment plan, ensuring that your path to wellness is customized just for you.
our advantage
Why Choose Leadwest Medical?
At Leadwest Medical, we understand that choosing a weight loss treatment is a significant decision. Our goal is to make your journey as seamless and effective as possible by offering personalized care and proven results. Here’s why Leadwest Medical stands out from the rest:
- Personalized Treatment Plans tailored to your unique health needs and goals
- Competitive and Transparent Pricing starting at just $151 per month
- Convenient Virtual Consultations from the comfort of your home
- Proven Success with Semaglutide/Tirzepatide and significant weight loss results
By choosing Leadwest Medical, you are selecting a partner dedicated to your health and well-being. Our comprehensive approach ensures that you receive the most effective treatment tailored to your individual needs, supported by a team of experts committed to your success. Start your journey to a healthier, happier you today.
INSURANCE
Flexible Coverage Options for Your Semaglutide Treatment
At Leadwest Medical, we understand that every patient’s financial situation is unique. That’s why we offer our Semaglutide treatment, including the active substances in Ozempic® and Wegovy®, with flexible insurance coverage options. Many insurance plans cover these clinically effective GLP-1 medications, making your journey to better health more affordable.
Whether your treatment is covered by insurance or you opt for our cost-effective compounded Semaglutide, we ensure you receive the same high-quality care and support. Our team is here to assist you in navigating your insurance benefits and finding the best financial solution for your needs.
GLP Dose Calculator
Affordable, Clinically Effective Weight Loss with Semaglutide (Ozempic® & Wegovy®) Covered by Insurance or Starting at $151 per month
Getting started
How It Works
Sign Up for Care
Create an account and answer some questions about your health. It shouldn't take more than 5 minutes!
Schedule Your Care
Select a Leadwest medical provider and be seen right away or schedule a visit in advance. We have same-day appointments.
Meet with Provider
Get treatment from a highly trained Leadwest medical provider including diagnosis and prescription if appropriate.
Start Feeling Better
Get Rx if medically appropriate delivered to your home or picked up at a pharmacy. Message with your care team and schedule follow-ups.
pricing information
Transparent Pricing
Our pricing is straightforward and transparent. Starting at $151 monthly, the cost may vary based on your specific dosage and treatment plan. Payments are made monthly, with an additional shipping fee of $20. Dosages and prices may change based on individual results to ensure you receive the most effective treatment.
Weight loss faq
Your Questions About Semaglutide Answered
Semaglutide is a prescription medication used to treat type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of the naturally occurring hormone GLP-1 in the body. Tirzepatide mimics the GIP pathway in addition to the GLP-1 pathway.
These medications help regulate blood sugar levels. They also slow down the rate at which food moves through the stomach, which can reduce appetite and promote weight loss.
They are typically administered as a once-weekly injection. The appropriate dose will depend on the patient’s individual needs.
They are not a substitute for a healthy diet and exercise, and should be used in conjunction with these lifestyle changes to achieve optimal results. As with any medication, it is important to talk to your healthcare provider about the potential benefits and risks of these medications and whether they are the right choice for you.
These medications are used to treat type 2 diabetes and obesity.
Type 2 diabetes: They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. They may be used alone or in combination with other diabetes medications.
Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol.
Semaglutide is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis. It is also not recommended for use in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as semaglutide may increase the risk of these conditions.
As with any medication, they should only be prescribed by a healthcare provider who has evaluated the patient’s medical history, current health status, and individual needs and goals. Patients should follow their healthcare provider’s instructions for use and attend regular follow-up appointments to monitor progress and assess the need for continued treatment.
These medications can cause side effects in some patients. Some of the commonly reported side effects include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Loss of appetite
- Headache
- Fatigue
- Dizziness
These side effects are usually mild to moderate in intensity and tend to improve over time as the body adjusts to the medication. However, if these side effects persist or become severe, patients should contact their healthcare provider for further evaluation and guidance.
In rare cases, they can cause more serious side effects such as:
- Pancreatitis (inflammation of the pancreas)
- Hypoglycemia (low blood sugar)
- Kidney problems
- Gallbladder problems
- Allergic reactions
Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, persistent nausea or vomiting, rapid heartbeat, difficulty breathing, or swelling of the face, lips, tongue, or throat.
Up to 20% with Semaglutide and up to 27% with Tirzepatid
Semaglutide and Tirzepatide are currently approved by the FDA for long-term use in the treatment of obesity.
Patients who stop the medication gain back on average two thirds of the weight they had lost. It is recommended that patients remain on a maintenance dose to curb cravings and maintain the new weight.
If your prior authorization is declined, your insurance will not cover the cost of the prescribed medication. In this instance, you have the option to self-fund your medication via our partnered pharmacies.
If you wish to share lab results, images, or any other relevant documents with your physician, you need to log into your PracticeBetter portal. Once there, select ‘Documents’ from the options in the left-hand column. Then, find and click on the red button located at the bottom right corner, which will allow you to upload the desired documents.
The cost details of all our plans are clearly exhibited on our website. The flat-fee displayed for each plan is the total amount you’ll be required to pay each month or contact us today .